2015
DOI: 10.1016/j.ejphar.2015.02.043
|View full text |Cite
|
Sign up to set email alerts
|

A step ahead of PPARγ full agonists to PPARγ partial agonists: Therapeutic perspectives in the management of diabetic insulin resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0
4

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(29 citation statements)
references
References 59 publications
0
23
0
4
Order By: Relevance
“…Semple reviewed the function of PPARγ and its variants in metabolic syndrome . In addition, Jia, Chigurupati and Vallée analysed therapeutic potential of PPARγ agonists in diabetes. PPARγ agonists improve insulin sensitivity and treat complications of diabetes.…”
Section: Function and Cellular Roles Of Pparγmentioning
confidence: 99%
See 1 more Smart Citation
“…Semple reviewed the function of PPARγ and its variants in metabolic syndrome . In addition, Jia, Chigurupati and Vallée analysed therapeutic potential of PPARγ agonists in diabetes. PPARγ agonists improve insulin sensitivity and treat complications of diabetes.…”
Section: Function and Cellular Roles Of Pparγmentioning
confidence: 99%
“…26 However, the undesirable side effects, such as fluid retention, weight gain, cardiac hypertrophy and hepatotoxicity, have limited the clinical use of TZDs. 5 Thus, searching for drugs with a similar clinical function, but fewer side effects has become a new direction of effort. Natural products are rich sources of drug discovery; thus, natural products are a focus of research.…”
Section: Ppa Rγ Agonis Ts From Natur Al Produc Tsmentioning
confidence: 99%
“…PPARs are members of the nuclear hormone receptors' superfamily and are essential in the regulation of cellular differentiation, development, metabolism and tumorigenesis of higher organisms (Singh et al, 2011). PPAR-g is a key regulator of insulin sensitization and glucose metabolism (Chigurupati et al, 2015), and PPAR-g activation is extremely effective in improving glycemic management; however, little is known about the metabolism of bavachinin.…”
Section: Introductionmentioning
confidence: 99%
“…Ở mô gan, mặc dù biểu hiện với lượng rất nhỏ nhưng thụ thể này có ảnh hưởng mạnh đến điều hòa con đường chuyển hóa glucose 5,6 . Thiazolidiodine đã được dùng làm thuốc để tăng hoạt tính thụ thể PPAR trong điều trị bệnh tiểu đường type 2 kháng insulin 7,8 . Việc suy giảm biểu hiện của thụ thể này ở gan được ghi nhận ở chuột nhắt với chế độ ăn nghèo năng lượng và tăng biểu hiện khi cho ăn nhiều lipid 9 .…”
Section: Giới Thiệuunclassified